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Abstract 
Introduction: A green protocol will be used to synthesize a novel series of 3-cyano-5- arylazo-pyridones (9a-c) and 
(10d-i).  
Methodology: Structures of the new products will be confirmed on the basis of spectroscopic data (FT-IR, 1D, NMR) 
as well as alternative synthetic routes, anticancer cell-line will be investigated and also molecular docking studies will be 
applied.  
Results: The activity against different cancer cell-line will be studied. Compounds with electron withdrawal group 
showed the highest activities. 
Introduction 
It was found that cancer is a fatal disease and it is the 2
nd
 one around the world after heart failure, Pyridone derivatives, 
pyridone nucleus containing compounds, and most of pyridine skeleton compounds are very important for researchers in 
chemistry as well as biology because large number of these compounds are found in nature, especially 2-pyridone ring 
system which imposes a great spectrum of biological activities  as anticancer drugs, antibacterial, and antimicrobial, 
antituberculosis, and many other biological activities.
1,2
 In addition some of cyano derivatives of pyridone are used in 
manufacture of dyes
3
. Other isomers of 2-pyridone is 4-pyridone which has magnetic properties which can be used in 
synthesis of liquid crystals and has antioxidant properties which can be used as drug in hyperglycemia
4
 
Guareschi-Thorpe described a general method by condensation of dicarbonyl compounds with cyanoacetamide 
5, 6
 which 
is about 3-2 type of condensation leads to formation of pyridone.
7
 
In most of these approaches, variety of 2-pyridone derivatives has been synthesized through introducing different 
functional groups on the pyridone ring. Development of potent and effective anticancer drugs is one of the more pressing 
goals of current medicinal chemistry.
8,9
 Various nucleosides have been reported to have important biological properties.
10
 
In particular, 4-Amino-3-fluoro-1-(β-D-ribofuranosyl)-2(1H)-pyridone 1 inhibits the growth of HL-60 lymphoid leukemia cells 
with IC50 =1.07 x 10-5 M, while 2'-deoxy analogue of 1 is active against lymphoid leukemia L1210 cells. Also, the acetyl 
derivative of 1 exhibits similar albeit less potent activities than 1.
11
 Selective inhibitors for the human immunodeficiency 
virus type1 reverse transcriptase (HIV-RT) are derivatives of pyridine. For example, 3-(4,7-Dimethyl benzoxazol-2-yl)-
amino-5-ethyl-6-methyl pyridine-2(1H)-one 2 and its 4,7-dichloro analogue have been reported to inhibit the spread of HIV-
1 infection by 95% in MT4 cell culture and were selected for clinical trials as antiviral agents. 4-Benzylpyridone 
10
 has been 
shown to possess potent HIV-1 specific reverse transcriptase inhibitor properties.
12
 (figure 1) 
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Figure 1: Some 2-pyridone derivatives have important biological properties. 
In the last century, the heating techniques for organic processes have not changed much, during which the oil-bath and 
heating mantle have been the most common heating methods. Recently, microwave-enhanced organic synthesis methods 
have attracted a great attention. In addition, microwave heating devices are an environmentally friendly energy source due 
to the following reasons: 
a) Their ability to rapidly heat reaction mixtures to produce the desired product with high selectivity,  
b) The energy consumption is only a fraction of that used for classical heating,  
c) With rapid heating to high temperatures under pressure, microwave irradiation permits a minimum amount of solvents of 
low boiling point to work efficiently, producing a minimum of byproducts.
13-15
 
In organic chemistry, microwave technology has only been implemented since the mid-1980s because of the lack of 
controls and reproducibility and because of some safety aspects.
16
 In recent years, these difficulties have been overcome 
and many successful organic reactions with radically enhanced reaction rates have been performed.
15, 17-21
 
In the electromagnetic spectrum, the microwave frequencies are located between infrared radiation and radio waves (0.3 – 
300 GHz). In order to avoid interference with telecommunication and microwave radar, industrial and domestic microwave 
apparatuses are generally to the wavelength of 12.2 cm (2450 GHz) (Fig. 2).
17
 In the electromagnetic spectrum, the 
molecule vibrates in the infrared field and rotates in the microwave field as shown in Figure 2. 
 
 
Figure (2) 
Heating Mechanisms 
The magnetron-tube generates wave power for microwave processing. The electric field component is responsible for the 
heating, which occurs by two main mechanisms (Fig. 3, A and B):
19, 20, 21, and 22
 
Dipolar polarization mechanism:  
The substance that possesses a dipole moment will align itself with an external electric field. When the field oscillates, it 
causes the dipole molecules to rotate. If the rotating frequency of the molecules is not high enough to follow the field 
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frequency, because of molecular friction and collisions in a viscous liquid, there will be a phase difference and then energy 
will be lost producing dielectric heating (Fig. 3, A). 
Conduction mechanism: The second major interaction occurs when a solution contains ions which oscillate in 
the solution under the influence of an electric field (Fig. 3, B). This kinetic energy will be converted to heat because of the 
increased collision rate. In addition, the rate of temperature increase is not only dependent on the dipolar polarization and 
conduction mechanisms but also on the emissivity, geometry and volume of the reaction mixture and the strength of the 
applied field.
19  
 
  
 
 
Figure (3) (A) Dipolar polarization mechanism, (B) Conduction mechanism. 
Microwave Equipments: 
Multi-mode ovens 
Many microwave-promoted organic syntheses have so far been conducted in domestic microwave ovens. In household 
ovens, the microwaves are randomly distributed within the cavity. Reflection of the microwaves generates a three 
dimensional stationary pattern of standing waves, called modes. In these multi-mode domestic ovens, a randomly 
distributed field pattern will be formed with high and low field strengths, generally referred to as “hot and cold spots” (Fig. 
4). 
 
Figure (4) Multi-mode oven. 
Therefore, when performing reactions in multi-mode ovens, there is a risk of getting poorly reproducible results because of 
the non-uniform heating and on and off cycles, especially if the temperature or pressure cannot be constantly monitored 
during the course of the reaction. 
Single-mode cavities 
In such mode, a continuous standing-wave is generated with well-defined regions of maximum and minimum field 
strengths. Consequently, a single-mode cavity delivers optimal reproducibility and energy efficiency, especially with an 
adequate temperature and pressure control system (Fig. 5).  
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Figure (5) CEM Microwaves 
The aims of our work are to synthesize some novel Polysubstituted-2-pyridones, to establish an easy direct method, to 
synthesize 2-Pyridone analogues, to study the mechanisms of these reactions, to confirm the obtained structures using 
different spectroscopic techniques, to study the biological activity of the obtained products, and to study the structural 
activity relationship. 
Results and Discussion 
A- Chemistry 
Synthesis of 3-cyano-4, 6-disubstituted-2-pyridones (9) under microwave irradiation 
without solvent and using a solid media. 
In microwave assisted organic synthesis the question is going to be whether the reaction should be carried out in a 
closed environment or at atmospheric pressure and using solvent or solvent less. The scale of the reaction will 
probably be the deciding factor. In present work, the pressurized conditions for the reactions were used. A 
pressurized environment can be very advantageous   to   many   different   kinds   of chemistries. Solvents can be 
heated up to temperatures that are two to four times their respective boiling points. This characteristic condition of 
microwave synthesis provides a large rate enhancement.
 
Also, pressurized reaction conditions also provide inert 
atmospheres for use of air and moisture sensitive reagents. Atmospheric reactions can be performed on a much 
larger scale than pressurized ones.  
From synthetic point of view, in spite of enormous literature on the utility of 1,3-dicarbonyl compounds in heterocyclic 
synthesis a little attention has been paid to their utility under microwave irradiation in the chemical transformations 
including such class of compounds and their synthesis without using solvent. Generally, the pyridone derivative (9) 
was readily obtained by irradiating equimolar quantities of substited 1,3 propanedione (4a-c) and cyanoacetamide (6) 
using silica gel as reaction medium under pressurized microwave conditions (Scheme 1). 
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Scheme 1 
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Table (1) substituted 1,3propanedione (9) under microwave irradiation 
Substituted 
1,3propanedione  
R1 R2 Yield % 
9a ـــCH3 ـــــCH3 70 
9b phــــ ـــــCH3 65 
9c 
S
 
ـــــCF3 51 
 
Table (2) substituted azo-pyridone 10(d-i) 
In order to achieve the optimized conditions suitable for the reaction, microwave irradiations were performed under 
different conditions of solid media, temperature, time and power in order to achieve the optimized conditions suitable for 
the reaction to prepare the main product (9a) 
Irradiation using different solid media 
Solution-phase reactions performed in the presence of solvent can be either homogeneous or heterogeneous. Microwave 
irradiation has been used extensively and successfully with homogeneous solution-phase reactions. These types of trans-
Substituted 
pyridone 
Ar R1 R2 
10d CH3
HO
 
ـــــCH3 ـــــCH3 
10e SO3H
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formations are widely used and highly successful. On the other hand the use of solids as a reaction medium is one of the 
green techniques used in green synthesis with high safety. 
The Type of the solid plays a significant role in microwave-assisted reactions. When different types of solid supports have 
been used as a media for such reaction, the reaction products were obtained in good to moderate yields (Table 1). 
Irradiating the reaction mixture without solvent using silica gel afforded the target pyridone in excellent yields (entry 3, 
Table 3). On the other hand, the product was obtained in moderate yields when alumina was used (entry 2, Table 2) The 
results of the change of solid supports on the yield of reaction product under microwave irradiation was summarized in 
Table 3. 
Table (3) Effect of the solvent 
Entry Solid 
mediuma 
Yield 
%b 
1  Alumina 65 
2  Calcinated 
Alumina 
70 
3  Silica Gel 86 
4  Polyethylene 
glycol 
56 
 
a 
The reactions were carried out using 1600 W microwave power for 7 min.  
i- Irradiation at different temperatures 
Next, the effect of temperature on the yield of reaction was investigated. The reaction was performed under different 
temperatures using the options of the CEM microwave machine. It was found that the best temperature for such kind 
of reactions is the 220
o
C  however higher temperature afforded almost the same yield or lower by small extant but the 
reaction product could not be isolated in a pure state due to some decomposition occurred. 
Table (4) Effect of Temperature 
Entry Temperature Yield%b 
1  60 19 
2  80 30 
3  90 35 
4  150 68 
5  150 80 
6  200 92 
7  220 88 
8  240 90 
Irradiation for different times 
The effect of the time of irradiation have been also investigated. As the time of irradiation increases, as the yield of the 
product increases. However after 7 min, the yield becomes constant. The maximum yield in such reaction was obtained 
after 7 minutes. Increasing the time to 10 min decreases the yield considerably due to decomposition. 
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Table (5) Effect of the time of irradiation 
 
 
 
 
 
 
 
 
 
 
a 
The reactions were carried out using 1600 W microwave power at 220 
o
C. 
b
 Isolated yields. 
ii- Irradiation using different powers 
The effect of different power of the microwaves was investigated and it was found that using 1600 W power was enough to 
afford a maximum yield of the reaction products.  
Table (6) Effect of the microwave power 
 
 
a 
The reactions were carried without solvent at 220 
o
C for 7 min.. 
 
b
 Isolated yields. 
From the previous investigations, it was found that using solvent less/ 1600 W/ 220
o
C/ 7 min. conditions for such 
reaction gave the optimum yield of the pyridone (9a).  
B- Biology 
Anticancer activity 
The newly synthesized compounds were tested for in vitro anticancer activity using SRB cytotoxicity assay method. The 
anticancer screening revealed that the synthesized compounds exhibited cytotoxic activity against MCF-7 Breast cancer 
cell lines and HEPG-2 Liver cancer cell lines in variable degrees. 
Compound (10e)  is more potent than (10d) compound on MCF-7 Breast cancer cells as its IC 50 % 75.2 Ug/ml compared 
to 98.57 for CRES compound. On the other side, compound (10d)  has a potent anticancer activity IC50 (55.03 Ug/ml) on 
HEPG-2 cell lines compared to that of (10e) compound (60.24Ug/ml).In this concern, El said et al 2012
25
 and Lv 
et.al.,2013
26
 reported that new 2- pyridone derivatives showed potent anticancer activity against HEPG2 cell lines and 
Entry Irradiation time (min)a Yield%b 
1  1 0 
2  2 21 
3  3 32 
4  5 73 
5  7 88 
6  8 88 
7  10 65 
Entry Irradiation Power (W)a Yield%b 
1  300 0 
2  400 18 
3  800 43 
4  1200 70 
5  1600 88 
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their activity increased synergistically when combined with γ-radiation. The anticancer activity could be mediated by 
arresting cells in the G0/G1 phase as previously determined by Salah et.al.,2015.
27
 by using flow cytometry. 
Table (7) Test for anticancer 
MCF-7 Breast Cancer      
        
        
10d        
    Mean SD Viability IC50% 
Ug/ml 
0 1.837 1.765 1.782 1.795 0.034 100 98.57 
6.25 1.675 1.654 1.627 1.652 0.022 92.05  
12.5 1.526 1.586 1.58 1,564 0.029 87.15  
25 1.489 1.497 1.503 1.496 0.006 83.38  
50 1.519 1.421 1.473 1.471 0.043 81.46  
100 0.743 0.814 0.780 0.779 0.031 43.41  
        
        
10e    Mean SD Viability IC50% 
0 1.906 1.883 1.806 1.865 0.046 100 75.2 
6.25 1.549 1.699 1.53 1.609 0.676 86.29  
12.5 1.511 1.506 1.501 1.506 0.004 80.75  
25 1.553 1.376 1.399 1.442 0.086 77.35  
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50 1.385 1.345 1.408 1.379 0.028 73.96  
100 1.476 0.766 0.579 0.613 0.130 32.87  
        
HEP G-11 (Hepatocytes cancer 
cell line) 
    
10d    Mean SD Viability IC50% 
Ug/ml 
0 0.558 0.509 0.580 0.549 0.032 100 55.03 
6.25 0.524 0.402 0.364 0.430 0.075 78.32  
12.5 0.440 0.424 0,406 0.423 0.015 77.11  
25 0.399 0.383 0.357 0.379 0.019 69.16  
50 0.349 0.396 0.316 0.354 0.036 64.42  
100 0.059 0.324 0.052 0.145 0.139 26.41  
        
10e    Mean SD Viability IC50% 
0 0.152 1.145 0.162 1.153 0.007 100 60.24 
6.25 0.095 1.122 0.105 0.107 0.0122 70.15  
12.5 0.113 0.063 0.138 0.104 0.0341 68.41  
25 0.075 0.088 0.124 0.096 0.0227 62.53  
50 0.08 0.078 0.089 0.082 0.0052 53.81  
100 0.06 0.063 0.067 0.063 0.0031 41.39  
Molecular Docking 
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vascular endothelial growth factor receptor 2 (VEGFR-2) is  is an important protein involved in angiogenesis process, 
compounds that can bind and inhibit these kinases will have a great role in treating various types of cancers (1). In this 
study compounds 10d-I were docked into the VEGFR-2 binding site to explore their binding mode and possible 
interactions. 3CP9 is the pdb file (2) used in docking process, it was downloaded, refined, water molecules were removed, 
hydrogen atoms were added and the active binding site was detected using MOE program. The synthesized compounds 
were docked into the active site, the obtained docking scores are presented in table (7). Compounds 10d and 10e showed 
lower score energy than the other derivatives with VEGFR-2. The p-hydroxyl group in compound 10d formed a hydrogen 
bond with Thr916 amino acid and the phenyl moiety showed an arene-cation interaction with Lys868 (Fig. 7). Compound 
10e formed arene-cation interaction with Lys868 amino acid through its phenyl moiety (Fig. 8).    
 
 
 
Figure (7): 2D and 3D interactions of comp. 10d with VEGFR2 binding site. 
 
 
Figure (8): 2D and 3D interactions of comp. 10e with VEGFR2 binding site. 
Table (7): Binding score (Kcal/mol) of compounds 10d-I with VEGFR2. 
Comp. No. Score energy (Kcal/mol) 
10d -13.67 
10e -14.58 
10f -9.45 
10g -10.94 
10h -11.51 
10i -7.95 
 
Methodology 
A- Chemistry 
All melting points were measured on a Gallenkamp melting point apparatus. The infrared spectra were recorded in 
potassium bromide discs on a Pye Unicam SP 3–300 and Shimadzu FT IR 8101 PC infrared spectrophotometers. The 
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NMR spectra were recorded on a Varian Mercury VXR-300 NMR spectrometer (
1
H NMR (300 MHz) and 
13
C NMR (75.46 
MHz)) were run in deuterated chloroform (CDCl3) or dimethyl sulfoxide (DMSO-d6). Chemical shifts were related to that of 
the solvent. Mass spectra were recorded on a Shimadzu GCMS-QP1000 EX mass spectrometer at 70 eV. Elemental 
analyses were carried out at the Micro-analytical Centre of Cairo University, Giza, Egypt and recorded on Elementar-Vario 
EL automatic analyzer. The Microwave reactor was used in this work is the CEM mars machine. CEM has several vessel 
types that are designed for their ovens: (1) Closed-system vessels including the HP-500 (500 psig material design pressure 
and 260 °C), pictured below, have liners are composed of PFA and are ideal for many types of samples. HP-500 Plus 
vessels are ideal for routine digestion applications. Process up to 14 high-pressure vessels per run with temperatures up to 
260 °C or pressures up to 500 psi.  
A number of safeguards have been incorporated in the MARS 5 system to eliminate the possibility of an explosive high 
pressure material failure. Each reaction vessel fits within a microwave-transparent sleeve made of Kevlar, and each 
vessel-sleeve assembly gets clamped within a carriage or 'support module' with 5 foot-pounds of torque applied to the 
clamping bolt. A plastic membrane pressure rupture disc that fits between the exhaust port in the vessel lid and the 
threaded blue cap (shown in figure 1, and 2) ensures the digestion takes place under completely closed conditions at 
lower pressures. The blue cap has a small hole drilled in it. Should pressures exceed what is safe for the particular vessel 
the membrane will rupture, exhausting gas through the port in the vessel lid and the cap and into the oven, which exhausts 
into a fume hood. The microwave oven also has a rupture pressure sensor that stops the power to the microwave if it 
detects a sudden pressure change. 
Microwave method 
Synthesis of 3-cyano-4,6-disubstituted-2-pyridones 9(a-c) and 3-cyano-4,6-
disubstituted-5-arylazo-2-pyridones 10 (d-i) 
To a mixture of cyanoacetamide (6) (100 mmole) in silica gel (5 g) was added 1,3-dicarbonyl compound (4) (100 mmol) 
and equivalent amount of potassium hydroxide. The mixture was grinded well in a mortar and then was charged in a HP-
500 Plus process vessel. The vessel was capped properly and irradiated by microwaves under pressurized conditions 
(17.2 bar, 220
o
C) for certain time (see table 2). After irradiation the reaction mixture was cooled and ethyl acetate/DMF 
mixture was added then sonication of the solution for one hour to extract the reaction product was done. Filtration of the 
mixture in a centered glass and the solvent was evaporated in vacuo gave solid was recrystallized from EtOH/DMF to 
afford  (9), The reaction was indicated by TLC 
Conventional method (Method B):  
A mixture of cyanothioacetamide (6) (10 mmol), propane-1,3-dione derivatives (4) or 2-arylhydrazono-1,3-
diphenylpropane-1,3-diones (5) (10 mmol) will be suspended in ethanol (30 ml) containing potassium ethoxide (0.68 g, 10 
mmol). The mixture will be refluxed for long time, and then will be allowed to stand overnight. The resultant precipitate wil l 
be filtered and crystallized from the appropriate solvent to give the solid products as potassium salts (9) and (10). The 
potassium salt will be dissolved in water at 80°C, filtered and neutralized with dilute hydrochloric acid (1M). The resulting 
solid product will be collected by filtration and washed with distilled water to remove sodium chloride. The product will be 
dried prior to crystallization from EtOH-DMF to afford the products (9) and (10). 
Table (9) Comparison between microwave method and conventional method in synthesis of 
(10d-i) 
Compound 
number 
Microwave Conventional  
Reaction time 
(min.) 
Yield Reaction time 
(hrs) 
yield 
10d 4 90 7 71 
10e 3 94 7 75 
10f 3 89 6 63 
10g 4 95 7 72 
10h 4 97 7 78 
10i 3 93 6 67 
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Figure (6)
3-Cyano-4,6 dimethyl-5arylazopyridone
10d-i
 
Table (10) The Spectral 1H NMR data of the synthesized compounds 
Compound 
number 
Spectral1H  NMR data 
9a δ 2.2(s,3H,CH3), 2.3(s,3H,CH3), 6.28(s, 1H, Ar-H) 
9b δ δ 2.3(s, 3H,CH3), 6(s, 1H,N-H), 6.5(s, 1H, Ar-H), 7.6-
7.9(m, 5H, Ar-H) 
9c δ 6.5(s, 1H), 6.8-7.1(m, 5H, Ar-H), 7.4(s, N-H) 
7.5(d,1H,thiophene-H), 7.7(s,1H,thiophene-H), 
7.8(d,1H,thiophene-H) 
10d δ 2.43(s,3H,CH3), 2.55(s,3H,CH3), 2.81(s,3H,CH3), 4.81(s, 
1H, OH), 7.28-7.91(m, 3H,Ar-H) 
10e δ  2.45(s, 3H,CH3), 2.57(s.3H,CH3), 7.11-7.81(m,4H,Ar-H) 
10f δ 2.47(s, 3H,CH3), 2.52(s,3H,CH3), 7.30(s,2H,NH2), 7.45-
8.06(m,4H,Ar-H) 
10g δ 2.47(s,3H,CH3), 2.57(s,3H,CH3), 3.65(s,3H,OCH3), 
3.81(s,3H,OCH3), 3.86(s,3H,OCH3), 6.94-7.11(m,2H,Ar-H) 
10h δ 2.4(s,3H,CH3), 2.48(s3H,CH3),3.63(s,3H,OCH3), 
3.78(s,3H,OCH3), 6.93-7.23(m,3H,Ar-H) 
10i δ 2.48(s,3H,CH3), 2.57(s, 3H,CH3), 7.01(s,2H,NH2), 6.91-
7.81(m,4H,Ar-H) 
 
B- Biology 
Material and methods 
Anticancer activity 
A- Cell culture 
The cells were obtained from Egyptian Holding Company for Biological Products & Vaccines (VACSERA), Giza, Egypt and 
then maintained in the tissue culture unit .The cells were grown in RBMI‐1640 medium, supplemented with 10% heat 
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inactivated FBS, 50 units/mL of penicillin and 50 mg/mL of streptomycin and maintained at
23
in a humidified atmosphere 
containing 5% CO2. The cells were maintained as monolayer culture by serial sub‐culturing. Cell culture reagents were 
obtained from Lonza (Basel, Switzerland). The anticancer activity of the rested compounds was evaluated against MCF‐7 
cells (Breast cancer), HEPG‐2 cells (Liver cancer). 
B- The sulforhodamine B (SRB) cytotoxicity assay 
Cytotoxicity was determined using the sulforhodamine B(SRB) assay method as previously described by Skehan et al.
24 
Exponentially growing cells were collected using 0.25% Trypsin‐EDTA and seeded in 96‐well plates at 1000‐2000 
cells/well in RBMI‐1640 supplemented medium. After 24 h, cells were incubated for 72 h with various concentrations of 
the tested compounds. Following 72 h treatments, the cells would be fixed with 10% trichloroacetic acid for 1 h at 4 °C. 
Wells were stained for 10 minutes at room temperature with 0.4% SRBC (Sulphorhodamine B) dissolved in 1% acetic 
acid. The plates were air dried for 24 h and the dye was solubilized with Tris‐HCl for 5 min on a shaker at 1600 rpm. The 
optical density (OD) of each well was measured spectrophotometrically at 564 nm with an ELISA microplate reader 
(ChroMate‐4300, FL, USA). The IC50 values were calculated according to the equation for Boltzman sigmoidal 
concentration response curve using the nonlinear regression fitting models (Graph Pad, Prism Version 5) 
C- Molecular Docking 
Molecular docking studies were performed using Molecular Operating Environment software 10.2008 (MOE) provided with 
chemical computing group, Canada. Validation process was performed after downloading the 3CP9 file by removing and 
redocking of the co-crystalized ligand into the VEGFR-2 binding site. 2D structures of  the synthesized compounds were 
converted to 3D by MOE program, protonated, energy minimized using Merck Molecular force field (MMff 94x), saved as a 
data base file and docked into 3CP9 active site with a root mean standard deviation (RMDS) = 1.1027. Docking scores are 
represented in table 10, 2D and 3D interactions for the best docked compounds are presented in fig. 7 and fig. 8.   
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